View the biographies of Sarah Cannon leaders who are forging the way for innovative and effective cancer research and treatment.

Skip to main content

Sarah Cannon Leadership and Physician Experts

Our leadership team, including recognized physician experts and researchers, is at the forefront of shaping new standards of cancer care based upon the latest research. Patients are at the heart of everything we do. Sarah Cannon offers integrated cancer services, providing patients with cutting-edge treatments and upholding the highest quality care for patients from diagnosis through survivorship.

Sort by default

Amy Abbott, MHP

Regional Vice President, North Florida Division

Hendrik-Tobias Arkenau, MD, PhD, FRCP

Executive Medical Director, Drug Development Program; Principal Investigator

Carlos Bachier, MD

Director, BMT Research

Elizabeth (Liz) Bagwell

Associate Regional Vice President, TriStar Division

Minoo Battiwalla, M.D., M.S.

Director, Outcomes Research

Associate Director, Drug Development; Principal Investigator

Johanna C. Bendell, MD

Chief Development Officer; Director of the GI Cancer Research Program

Jesus G. Berdeja, MD

Director of Myeloma Research

Senior Director, Clinical Operations

Rocky Billups, MS

Vice President, Operations

Barrett K. Blackmon, MBA, FACHE

Regional Vice President, Gulf Coast Division

Andrea Buchmeier, MHA, CCRC, LSSGB

Associate Regional Vice President, Continental Division

Howard A. "Skip" Burris, III, MD

President, Clinical Operations and Chief Medical Officer

VP of Clinical Operations

Jonathan Connor

Assistant Vice President, Strategy and Development

Chief Information Officer

Tonya Cox, BSN, RN, OCN

Assistant Vice President of Operations

Holli Hutcheson Dilks, PhD

Director, Personalized Medicine Operations

Therese "Tracy" Dodd, BA, MBA, RN, CPHQ

Quality Improvement Director

William Bruce Donnellan, MD

Investigator, Hematologic Malignancies; Principal Investigator

Assistant Vice President, Clinical Operations

Gerald S. Falchook, MD, MS

Director, Drug Development

Ian W. Flinn, MD, PhD

Director, Lymphoma Research; Principal Investigator

Susan Garwood, MD

Director, Lung Cancer Program at Sarah Cannon Cancer Institute at TriStar Health

Richard Geer, MD

Physician-in-Chief, Surgical Oncology

Stephanie Graff, MD

Director, Breast Cancer Program at Sarah Cannon Cancer Institute at HCA Midwest Health; Associate Director, Breast Cancer Research Program, Sarah Cannon Research Institute

F. Anthony Greco, MD

Co-Founder

John D. Hainsworth, MD

Co-Founder; Principal Investigator

Ryan Hallenbeck

Regional Vice President, Cancer Services for Sarah Cannon Cancer Institute at HCA Midwest Health

Erika P. Hamilton, MD

Director, Breast Cancer and Gynecologic Cancer Research Program; Principal Investigator

Vice President, Business Innovation

Sybil Hyatt, MSN

Director of Operations, Cardiovascular Research

Raymond Jackson, RN, MBA

Regional Vice President, South Atlantic Division

Melissa Johnson, MD

Associate Director, Lung Cancer Research

Assistant Vice President and Legal Counsel

Suzanne Jones, PharmD

Senior Director, Scientific Director, Strategic Development; Principal Investigator

Andrew Kennedy, MD

Physician-in-Chief, Radiation Oncology, Sarah Cannon; Director, Radiation Oncology Research

Samantha Kirby, MHA

Regional Vice President, TriStar Division

Dax Kurbegov, MD

Vice President & Physician-in-Chief of Clinical Programs

Vice President, Human Resources

Fred LeMaistre, MD

Senior Vice President, Sarah Cannon Market Operations and Physician-in-Chief of Blood Cancers

Margaret C. Mazzone

Vice President, Legal Counsel; Ethics and Compliance Officer

Associate Vice President, Corporate Affairs

Frances M. Palmieri RN, MSN, OCN, CCRP

Director Oncology Strategic Sites

Zahra Raki, RN, MBA

Regional Vice President, Continental Division

Ethel Randall, MBA, RTM

Regional Vice President, South Atlantic Division

Chief Financial Officer

Hillary Rosenfeld, FACHE, MBA, MSN

Associate Regional Vice President, Capital Division

Senior Investigator, Neuro-Oncology Program; Principal Investigator

Chief Executive Officer

David Spigel, MD

Chief Scientific Officer; Director, Lung Cancer Research Program; Principal Investigator

Melissa Threlkeld, FACHE, MHA

Regional Vice President, HCA North Texas

Jonathan Tinker, MHA, MBA

Regional Vice President, Capital Division

Vice President, Strategic Development

Susan Woods, MBA, BSN, RN

Vice President of Market Operations for Cancer Services

Vice President, Development Innovations

Denise A. Yardley, MD

Senior Investigator, Breast Cancer Research Program; Principal Investigator